These findings are in agreement with previous observations in which SLC22A17 expression is strictly regulated by methDNA status in childhood acute lymphoblastic leukemia and chronic musculoskeletal pain [68, 69]. This evidence concerns the gene SLC22A17 and acute lymphoblastic leukemia.